PL3960195T3 - Engrailed do zastosowania w leczeniu stwardnienia zanikowego bocznego - Google Patents
Engrailed do zastosowania w leczeniu stwardnienia zanikowego bocznegoInfo
- Publication number
- PL3960195T3 PL3960195T3 PL21189549.5T PL21189549T PL3960195T3 PL 3960195 T3 PL3960195 T3 PL 3960195T3 PL 21189549 T PL21189549 T PL 21189549T PL 3960195 T3 PL3960195 T3 PL 3960195T3
- Authority
- PL
- Poland
- Prior art keywords
- engrailed
- treatment
- lateral sclerosis
- amyotrophic lateral
- amyotrophic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychiatry (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15306482 | 2015-09-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3960195T3 true PL3960195T3 (pl) | 2025-06-09 |
Family
ID=54207439
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21189549.5T PL3960195T3 (pl) | 2015-09-23 | 2016-09-23 | Engrailed do zastosowania w leczeniu stwardnienia zanikowego bocznego |
| PL16777596T PL3352777T3 (pl) | 2015-09-23 | 2016-09-23 | Engrailed do stosowania w leczeniu uszkodzenia dna u pacjentów cierpiących na chorobę parkinsona |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16777596T PL3352777T3 (pl) | 2015-09-23 | 2016-09-23 | Engrailed do stosowania w leczeniu uszkodzenia dna u pacjentów cierpiących na chorobę parkinsona |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20190247461A1 (https=) |
| EP (2) | EP3352777B1 (https=) |
| JP (1) | JP6860575B2 (https=) |
| CN (1) | CN108289929A (https=) |
| ES (2) | ES2895154T3 (https=) |
| PL (2) | PL3960195T3 (https=) |
| WO (1) | WO2017071889A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120676931A (zh) | 2023-01-13 | 2025-09-19 | 布瑞恩维公司 | Engrailed蛋白的稳定水性组合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2662698A1 (fr) | 1990-06-05 | 1991-12-06 | Centre Nat Rech Scient | Nouveaux facteurs de croissance neurotropes comprenant un peptide homeoboite. |
| FR2855178B1 (fr) * | 2003-05-20 | 2005-08-05 | Centre Nat Rech Scient | Peptides modulateurs de l'activite du facteur de transcription engrailed |
| FR2897780B1 (fr) | 2006-02-28 | 2008-05-23 | Centre Nat Rech Scient | Utilisation de la proteine a homeodomaine engrailed comme anxiolytique |
| GB0625321D0 (en) * | 2006-12-19 | 2007-01-24 | Univ Surrey | Cancer biomarker |
| FR2926023B1 (fr) | 2008-01-09 | 2010-02-26 | Centre Nat Rech Scient | Utilisation d'une homoproteine de la famille bicoid pour le traitement du glaucome. |
| RU2012100903A (ru) * | 2009-07-13 | 2013-08-20 | Зе Юниверсити Оф Саррей | Терапевтические пептиды, полипептиды и последовательности нуклеиновых кислот |
| WO2013128239A1 (en) * | 2012-02-29 | 2013-09-06 | Centre National De La Recherche Scientifique | Use of engrailed for increasing dopamine synthesis by dopaminergic neurons |
-
2016
- 2016-09-23 EP EP16777596.4A patent/EP3352777B1/en active Active
- 2016-09-23 CN CN201680059070.1A patent/CN108289929A/zh active Pending
- 2016-09-23 PL PL21189549.5T patent/PL3960195T3/pl unknown
- 2016-09-23 PL PL16777596T patent/PL3352777T3/pl unknown
- 2016-09-23 EP EP21189549.5A patent/EP3960195B1/en active Active
- 2016-09-23 JP JP2018534025A patent/JP6860575B2/ja active Active
- 2016-09-23 US US15/761,702 patent/US20190247461A1/en not_active Abandoned
- 2016-09-23 ES ES16777596T patent/ES2895154T3/es active Active
- 2016-09-23 ES ES21189549T patent/ES3010130T3/es active Active
- 2016-09-23 WO PCT/EP2016/072675 patent/WO2017071889A1/en not_active Ceased
-
2021
- 2021-06-16 US US17/349,746 patent/US20210379144A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3960195B1 (en) | 2025-01-08 |
| JP2018536697A (ja) | 2018-12-13 |
| PL3352777T3 (pl) | 2022-02-07 |
| EP3352777A1 (en) | 2018-08-01 |
| EP3960195A1 (en) | 2022-03-02 |
| WO2017071889A1 (en) | 2017-05-04 |
| CA2999209A1 (en) | 2017-05-04 |
| CN108289929A (zh) | 2018-07-17 |
| US20210379144A1 (en) | 2021-12-09 |
| ES3010130T3 (en) | 2025-04-01 |
| US20190247461A1 (en) | 2019-08-15 |
| ES2895154T3 (es) | 2022-02-17 |
| JP6860575B2 (ja) | 2021-04-14 |
| EP3352777B1 (en) | 2021-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283086A (en) | Use of cannabidiol in the treatment of tuberous sclerosis complex | |
| MA45192A (fr) | Traitement d'association | |
| IL256166B (en) | Compounds for use in treating neuromuscular disorders | |
| HUE061761T2 (hu) | Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében | |
| PL3157512T3 (pl) | Zastosowanie kannabidioli w leczeniu padaczki | |
| PL3265053T3 (pl) | Sposoby leczenia skóry | |
| PL3429571T3 (pl) | Kombinacje inhibitorów lsd1 do zastosowania w leczeniu chorób nowotworowych | |
| PT3185957T (pt) | Patisiran para utilização no tratamento de amoloidose mediada por transtirretina | |
| DK3474802T3 (da) | Medicinsk forbinding | |
| DK3778595T3 (da) | Pancreatitisbehandling | |
| PL3503890T3 (pl) | Stosowanie pridopidyny w leczeniu dystonii | |
| EP3409744A4 (en) | SURFACE TREATMENT AGENT | |
| EP3380200A4 (en) | COMPOSITIONS FOR TREATING THE HAIR | |
| PL3381451T3 (pl) | Kompozycja farmaceutyczna stosowana do redukcji zlokalizowanej tkanki tłuszczowej i zastosowanie kompozycji farmaceutycznej | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| MA41794A (fr) | Agents thérapeutiques modifiés et compositions associées | |
| EP3431566A4 (en) | SURFACE TREATMENT AGENT | |
| EP3310376A4 (en) | MODIFIED THERAPEUTIC AGENTS AND COMPOSITIONS THEREOF | |
| PL3236960T3 (pl) | Fluralaner do zastosowania w leczeniu demodekozy | |
| EP3380063A4 (en) | COMPOSITIONS FOR TREATING THE HAIR | |
| PL3229794T3 (pl) | Kombinacja farmaceutyczna obejmująca ponesimod i jej zastosowanie w leczeniu stwardnienia rozsianego | |
| DK3302519T3 (da) | Ornithodoros-moubata-komplement-inhibitor til anvendelse i behandlingen af akut graft-versus-host-sygdom | |
| IL251904B (en) | Apilimod for use in the treatment of melanoma | |
| HUE053927T2 (hu) | Farneziltranszferáz inhibitorok rák kezelésében történõ alkalmazásra | |
| PL3592355T3 (pl) | Kx2-391/kx-01 do zastosowania w leczeniu rogowacenia słonecznego |